Fibromyalgia in patients with axial spondyloarthritis: Epidemiological profile and effect on measures of disease activity

Rheumatology International

Volumn 34, Issue 8, 2014, Pages 1103-1110

  Salaffi, Fausto ^a   De Angelis, Rossella ^a   Carotti, Marina ^a   Gutierrez, Marwin ^a   Sarzi Puttini, Piercarlo ^b   Atzeni, Fabiola ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ASDAS; BASDAI; Disease activity; Fibromyalgia; Prevalence; Spondyloarthritis

Indexed keywords

C REACTIVE PROTEIN; AUTACOID; BIOLOGICAL MARKER;

ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROMYALGIA; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SPONDYLARTHRITIS; ADULT; AGED; ARTHRITIS, PSORIATIC; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISABILITY; ITALY; MIDDLE AGED; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

ADULT; AGED; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; FIBROMYALGIA; HUMANS; INFLAMMATION MEDIATORS; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84904857117     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-2955-9     Document Type: Article

References (52)

1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379-1390
2. Gladman DD (1998) Clinical aspects of the spondyloarthropathies. Am J Med Sci 3:234-238
3. van der Linden S, van der Heijde D (1998) Ankylosing spondylitis: clinical features. Rheum Dis Clin North Am 24:663-676
4. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 18(7):25
5. Salaffi F, De Angelis R, Grassi W, MArche Pain Prevalence; INvestigation Group (MAPPING) study (2005) Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 23:819-828
6. Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P (2011) Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol 25:165-171
7. Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W (2009) Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 27(5 Suppl 56):S67-S74
8. Dernis-Labous E, Messow M, Dougados M (2003) Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology 42:1523-1528
9. Atzeni F, Sallì S, Benucci M, Di Franco M, Alciati A, Sarzi-Puttini P (2012) Fibromyalgia and arthritides. Reumatismo 64:286-292
10. Wolfe F, Michaud K (2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31:695-700
11. Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27:865-868
12. Almodóvar R, Carmona L, Zarco P, Collantes E, González C, Mulero J et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):S33-S39
13. Marchesoni A, Atzeni F, Spadaro A, Lubrano E, Provenzano G, Cauli A et al (2012) Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 39:849-855
14. Magrey MN, Antonelli M, James N, Kahn MA (2013) High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study. Arthritis. doi:10.1155/2013/762921
15. Azevedo VF, dos Santos Paiva E, Hiurko Felippe LR, Moreira RA (2010) Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Rheumatol 50:646-654
16. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
17. Rudwaleit M, van der Heijde D, Landewe' R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777-783
18. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600-610
19. Garrett SL, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining functional ability in ankylosing spondylitis: the Bath Ankylosing Spondylitis Functional Index (BASFI). J Rheumatol 2:2286-2291
20. Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W (2005) Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 57:161-173
21. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18-24
22. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewe R (2008) The ASDAS is a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811-1818
23. Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D (2011) Assessment of the SpondyloArthritis International Society. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47-53
24. Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Anky-losing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66-71
25. Swetz JA (1988) Measuring accuracy of diagnostic systems. Science 240:1285-1293
26. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839-843
27. Staud R (2006) Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr Rheumatol Rep 8:430-435
28. Ostuni P, Botsios C, Sfriso P, Punzi L, Chieco-Bianchi F, Semerano L et al (2002) Fibromyalgia in Italian patients with primary Sjogren's syndrome. Joint Bone Spine 69:51-57
29. Konno T (2012) Differentiation of the clinical features of psoriatic arthritis and fibromyalgia. J Rheumatol 39:11
30. Fitzcharles MA, Boulos P (2003) Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology 42:263-267
31. Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F (2011) Clinimetric evaluations of patients with chronic widespread pain. Best Pract Res Clin Rheumatol 25:249-270
32. Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F (2009) Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 27(5 Suppl 56):S92-S105
33. Wolfe F, Clauw DJ, Fitzcharles MA et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600-610
34. Salaffi F, Sarzi-Puttini P (2012) Old and new criteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin Exp Rheumatol 30(6 Suppl 74):3-9
35. Gutierrez M, Di Geso L, Salaffi F, Bertolazzi C, Tardella M, Filosa G, Filippucci E, Grassi W (2012) Development of a preliminary US power Doppler composite score for monitoring treatment in PsA. Rheumatology (Oxford) 51:1261-1268
36. Gutierrez M, Luccioli F, Salaffi F, Bartoloni E, Bertolazzi C, Bini V et al (2012) Ultrasound revealing subclinical enthesopathy at the greater trochanter level in patients with spondyloarthritis. Clin Rheumatol 31(3):463-468
37. Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W (2011) Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis 70:1111-1114
38. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000-1008
39. Salaffi F, Sarzi-Puttini P, Girolimetti R, Gasparini S, Atzeni F, Grassi W (2009) Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect. Arthritis Res Ther 11:R125
40. Heikkila S, Ronni S, Kautiainen HJ, Kauppi MJ (2002) Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol 29:1415-1419
41. Coates LC, Mumtaz A, Helliwell PS, Mease PJ, Callis-Duffin K, Krueger G et al (2011) Development of a disease severity and responder index for psoriatic arthritis (PsA)-report of the OMERACT 10 PsA special interest group. J Rheumatol 38:1496-1501
42. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1-ii44
43. Slobodin G, Reyhan I, Avshovic N, Balbir-Gurman A, Boulman N, Elias M et al (2011) Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol 30:1075-1080
44. Pedersen SJ, Sorensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS et al (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065-1071
45. Nas K, Yildirim K, Cevik R, Karatay S, Erdal A, Baysal O et al (2010) Discrimination ability of ASDAS in estimating disease activity status in patient with ankylosing spondylitis. Int J Rheum Dis 13:240-245
46. Mas AJ, Carmona L, Valverde M, Ribas B, the EPISER Study Group (2008) Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 26:519-526
47. Hughes G, Martinez C, Myon E, Tai C, Wessely S (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54:177-183
48. Kivimäki M, Leino-Arjas P, Kaila-Kangas L, Virtanen M, Elovainio M, Puttonen S et al (2007) Increased sickness absence among employees with fibromyalgia. Ann Rheum Dis 66:65-69
49. Ofluoglu D, Berker N, Güven Z, Canbulat N, Yilmaz IT, Kayhan O (2005) Quality of life in patients with fibromyalgia syndrome and rheumatoid arthritis. Clin Rheumatol 24:490-492
50. Hawley DJ, Wolfe F (1991) Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol 18:1552-1557
51. Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, van der Linden S (2005) Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 64:396-402
52. Aydin SZ, Can M, Atagunduz P, Direskeneli H (2010) Active disease requiring TNF-alpha antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol 28:752-755